May 07–10, 2026 | Park Plaza Riverbank London, London, United Kingdom
Scientific Organizers:
Karen Akinsanya, Alexander Hillisch, Najat Khan, and Gang Liu

-
Scientific Organizers: Karen Akinsanya, Alexander Hillisch, Najat Khan, and Gang Liu
Karen Akinsanya
Alexander Hillisch
Najat Khan
Gang Liu
***Meeting program subject to change.
Available Formats: = Livestream = In Person = On DemandBooking Function
Thursday, May 7, 2026
Fundraising
Merchandise Options
Registration Options
Friday, May 8, 2026
Development and Application of an AI-First Drug Design Platform at Isomorphic Labs
Computational Drug Design across Different Modalities
Computational Advances in Discovering Cryptic Pockets for Drug Discovery
Drugging the Undruggable: Leveraging Computational Techniques to Drive Compound Design
Harnessing Generative AI to Creation and Development of ABS-201: A Novel Anti-PRLR Antibody for Androgenic Alopecia
Peptide-MHCI (pMHCI) Binder Design
in silico Antibody Design
Saturday, May 9, 2026
Single Molecule Tracking in Drug Discovery and Systems Biology
Avoiding Funnels: Using Active Learning and Generative AI to Drive Drug Discovery
Complete Allosteric Maps for Drug Discovery
Digital Twins and In Silico Clinical Trials for Drug Discovery
Decoding Toxicology: Computational Frameworks for Next-Generation Predictive Safety
Human iPSC High-throughput Screening for Teratogenicity Hazard Identification
Sunday, May 10, 2026
Identification of High Confidence Candidate Markers for Macrophage Infiltrating Tumor Microenvironment Through Single Cell Genomic Atlases
The Kinase Polypharmacology Landscape of Clinical PARP Inhibitors
A Multimodal Digital Biomarker of Functional Deficits in Early‐Stage Alzheimer’s Disease
Diverse Application of AI in Drug Discovery at Novartis
Generative AI-Enabled Multi-Parameter Lead Optimization in Early Drug Discovery
Monday, May 11, 2026
Subscribe for Updates